Document:

exv10w7

 

			
	CONFIDENTIAL TREATMENT REQUESTED
	 	EXHIBIT 10.7 REDACTED

AMENDMENT THREE

TO THE

BILLING SERVICES AND LICENSE AGREEMENT

BETWEEN

VERISIGN, INC.

AND

RURAL CELLULAR CORPORATION

     THIS AMENDMENT THREE by and between VeriSign, Inc. (“VeriSign”) and Rural Cellular Corporation
(“RCC”) is made and entered into to be effective the date of the last signature hereto.

     WHEREAS, VeriSign and RCC are parties to that certain Billing Services and License Agreement,
dated to be effective July 21, 2005, as amended by that Amendment One between the parties,
effective June 20, 2006, and that Amendment Two between the parties, effective October 5, 2006
(hereinafter collectively referred to as “Agreement”); and

     WHEREAS, the parties hereto desire to amend the Agreement as provided herein;

     NOW, THEREFORE, in consideration of the premises and the covenants and undertakings set forth
herein, VeriSign and RCC agree as follows:

     1.       Section 3.B. Effective April 1, 2007, Section 3.B of the Agreement is replaced in its entirety
with the following:

                B. ***.

      

Page 1

			
	RCC Billing Services and License Agreement — Amendment Three
	 	VeriSign Proprietary

*** Information omitted and filed separately with the Securities and Exchange Commission
pursuant to a request for confidential treatment.

 

 

			
	CONFIDENTIAL TREATMENT REQUESTED
	 	EXHIBIT 10.7 REDACTED

2. Section 8.B. Effective April 1, 2007, the paragraph entitled “Hardware/Software Fee” in
Section 8.B of the Agreement shall be deleted in its entirety and replaced with the following:
“Hardware/Software Fee. ***.

3. Section 8.C. Effective April 1, 2007, ***.

4. ***.

5. Miscellaneous. The parties acknowledge and agree that this Amendment Three constitutes the
entire understanding and agreement between VeriSign and RCC with respect to the subject matter
hereof, and supersedes any and all prior or contemporaneous oral or written representation,
understanding, agreement or communication relating thereto. Capitalized terms used without
definition in this Amendment Three shall be given the meanings ascribed to them in the Agreement.
Except as hereby modified, the Agreement shall remain in full force and effect in all aspects
throughout the remainder of the term thereof.

     IN WITNESS WHEREOF, each of the parties hereto has made and caused this Amendment Three to be
duly executed for it on its behalf by its authorized representative, to be effective the date of
the last signature hereto.

     The signatories to this Amendment Three hereby warrant and represent that they have the
authority to execute this Amendment Three on behalf of the entity or entities for which they sign.

      

Page 2

			
	RCC Billing Services and License Agreement — Amendment Three
	 	VeriSign Proprietary

*** Information omitted and filed separately with the Securities and Exchange Commission
pursuant to a request for confidential treatment.

 

 

			
	CONFIDENTIAL TREATMENT REQUESTED
	 	EXHIBIT 10.7 REDACTED

     This Amendment Three does not bind or obligate either party in any manner unless duly
executed by an authorized representative.

	 	 	 
	VERISIGN, INC	 	
RURAL CELLULAR CORPORATION
	By: /s/ Mitch Peterson	 	
By: /s/ Ann Newhall
	Name: Mitch Peterson	 	
Name: Ann Newhall
	Title: Director of Operations	 	
Title: EVP/COO
	Date: 5-12-07	 	
Date: 5-7-02

 

Page 3

			
	RCC Billing Services and License Agreement — Amendment Three
	 	VeriSign Proprietary

*** Information omitted and filed separately with the Securities and Exchange Commission
pursuant to a request for confidential treatment.

 

 

			
	CONFIDENTIAL TREATMENT REQUESTED
	 	EXHIBIT 10.7 REDACTED

Exhibit A

***

I. ***.

II. ***.

III. ***.

IV. ***.

V. SPEEDNET

RCC shall have the option until *** to contract for speedNET Service ***. Should RCC select this
option, *** “speedNet Service” shall mean the modules and services described below:

	 	•	 	Direct Network Mediation or Secondary Mediation of all existing voice and content
feeds excluding GPRS nodes
	 
	 	•	 	Near real-time Pre-Processing of all existing voice and content feeds to include GPRS
formatting
	 
	 	•	 	Real-Time Audit Reporting of all existing voice and content feeds to include GPRS
	 
	 	•	 	Batch Analysis of all existing voice and content feeds excluding GPRS
	 
	 	•	 	UDR Search for all existing voice and content feeds excluding GPRS
	 
	 	•	 	Raw Record Search for all existing voice and content feeds excluding GPRS
	 
	 	•	 	CIBER Search for all Incollect and Outcollect usage
	 
	 	•	 	TAP Search for all Incollect and Outcollect usage
	 
	 	•	 	Subpoena Search for all existing voice feeds
	 
	 	•	 	Mutual/Reciprocal Compensation Reporting for all existing voice feeds
	 
	 	•	 	Network Reporting for all existing voice feeds
	 
	 	•	 	Up to 200 hours annually for support of switch upgrades for all existing voice and
content feeds including GPRS
	 
	 	•	 	Up to 200 hours annually for support of new enhancement requests and other product
support

VeriSign and RCC will negotiate in good faith the fees, if any, for services that are not included
above and that may be provided for GPRS Mediation in the event RCC is able to facilitate
discussions with the relevant third party switch vendor that will allow a feasibility
determination.

VI. ***.

 

Page 4

			
	RCC Billing Services and License Agreement — Amendment Three
	 	VeriSign Proprietary

*** Information omitted and filed separately with the Securities and Exchange Commission
pursuant to a request for confidential treatment.exv10w2

 

Exhibit 10.2

ADDENDUM 1 TO LICENSE AND DISTRIBUTION AGREEMENT

     THIS ADDENDUM 1 TO LICENSE AND DISTRIBUTION AGREEMENT (the “Addendum”) is made and dated as of
the Effective Date set forth below by and among BIOLASE Technology, Inc., a Delaware corporation
(the “Company”) and Henry Schein, Inc., a Delaware corporation (the “Distributor”) with reference
to the following facts:

     A. Distributor and Company entered into that certain License and Distribution Agreement (the
“Agreement”) dated as of August 8, 2006; and

     B. Distributor and Company desire to add provisions to the Agreement to provide for the
distribution by Distributor of the Company’s new ezlase diode laser system and associated
accessories and consumables.

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:

AGREEMENT

	1.	 	This Addendum shall become a part of the Agreement, and shall fully address all references to
ezlase in the Agreement, including, but not limited to, Recital A and Sections 1.2 and 6.1 of
the Agreement.
	 
	2.	 	This Addendum shall be effective April 1, 2007 (the “Effective Date”); however, purchases of
ezlase from Company in March 2007 shall be considered made as part of this Addendum and shall
apply toward Ezlase Minimums, as such term is defined below, for the period April 1, 2007
through March 31, 2008.
	 
	3.	 	Company’s ezlase diode laser system and associated accessories and consumables shall be added
to the definition of Products, but not to the definition of “Systems” (collectively, “Ezlase
Products”), in the Agreement.
	 
	4.	 	Distributor shall be the exclusive distributor of Ezlase Products in the Territory, subject
to performance criteria set forth in this Addendum. Company shall not sell the Ezlase Products
on a direct basis in the Territory, except as permitted by Section 5.20 of the Agreement,
which section the Parties hereby agree apply to the ezlase diode laser system despite the fact
that Ezlase Products are specifically excluded from the definition of Systems. For purposes of
applying Section 5.20 of the Agreement to the ezlase diode laser system, the Maximum Direct
Amount shall be $****.
	 
	5.	 	There shall be separate minimum purchase requirements for the ezlase laser system (“Ezlase
Minimum(s)”). Purchases of the ezlase laser system by Distributor shall not be credited toward
Minimum Purchase Requirements as such term is defined in the Agreement.

 

****Certain confidential information contained in this document, marked with four asterisks,
has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

1

 

	 	a.	 	The Ezlase Minimum for the period April 1, 2007 through March 31, 2008
(“First Ezlase Year”) shall initially be **** units.
	 
	 	b.	 	Distributor and Company shall review actual unit sales of ezlase from
Distributor to Customers for the quarter ending June 30, 2007. Parties shall negotiate
in good faith as to the need for a modification to the aforementioned Ezlase Minimum
for the First Ezlase Year, and such negotiation shall be substantially based ****.
	 
	 	 	 	Beginning on March 1, 2008 and continuing for each April 1 to March 31 year (an “Ezlase
Year”) in which Distributor will have exclusive distribution rights for Ezlase
Products, on March 1 Company and Distributor shall negotiate in good faith an Ezlase
Minimum for the ensuing Ezlase Year.
	 
	 	 	 	In the event that, at the end of an Ezlase Year, Distributor has not purchased the
Ezlase Minimum for the period, Company shall have the following options:

	 	i.	 	Continue on an exclusive basis for ****; or
	 
	 	ii.	 	Upon **** written notice:

	 	1.	 	Convert Distributor’s rights to distribute
Ezlase Products to a non-exclusive basis but allow continued
non-exclusive distribution for a minimum period of ****, after which
period Company has the option to withdraw Distributor’s rights to
distribute Ezlase Products; and
	 
	 	2.	 	Reduce to **** the Distributor Discount on
the ezlase diode laser system and reduce to **** the Distributor
Discount on any other Ezlase Products.

	 	c.	 	On ****, the MSRP for the ezlase diode laser system shall be $****; the
Distributor Discount shall be ****; and the Distributor Purchase Price shall be $****.
The Parties agree that current median average selling prices for diode laser systems
in North America range from $****-$****. Prices for other Ezlase Products will be
provided by Company to Distributor.
	 
	 	d.	 	Notwithstanding anything herein or in the Agreement to the contrary, the sole
recourse for failure to purchase the Ezlase Minimum in any period is the remedy set
forth in Section 5(b) above.

	6.	 	Section 4.1 of the Agreement shall apply to Ezlase Products, except that the Warranty Period
for the ezlase laser system shall be a **** limited warranty from the date of shipment from
Company’s facility, as set forth in the warranty statement accompanying the product.
	 
	7.	 	Section 6.1 of the Agreement is hereby supplemented as follows:

 

****Certain confidential information contained in this document, marked with four asterisks,
has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

2

 

	 	a.	 	So long as Distributor has exclusive distribution rights for Ezlase Products,
not only will it not distribute any dental laser systems specifically intended for use
in soft-tissue dental procedures other than ****, but it further will not commence
distribution of any dental laser system specifically intended for use in soft-tissue
dental procedures which is provided by any supplier with which Distributor does not at
the date of this Addendum have an existing distribution arrangement. For the avoidance
of doubt, and solely serving as an example, a violation of this provision would
include, but not be limited to, the distribution by Distributor of the **** or the
**** manufactured by ****.
	 
	 	b.	 	In the event of a failure to comply with Section 6.1(a) above, Company may
apply the provisions set forth in Section 5(b) above, or immediately withdraw
Distributor’s rights to distribute Ezlase Products. In the event that Company elects
to withdraw Distributor’s rights to distribute Ezlase Products, Distributor shall have
the right to continue to sell its remaining inventory of Ezlase Products after the
date Company withdraws Distributor’s rights to distribute Ezlase Products. Such sales
of Ezlase Products by Distributor shall otherwise be subject to the terms and
conditions set forth in the Agreement and this Addendum.

     IN WITNESS WHEREOF, the parties have executed this Addendum effective as of the Effective
Date.

	 	 	 	 	 	 	 	 	 
	COMPANY	 	 	 	DISTRIBUTOR  
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	BIOLASE Technology, Inc.	 	 	 	Henry Schein, Inc.
	 
	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:	 	 
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Name:

	 	 	 	 	 	Name:	 	 
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Title:

	 	 	 	 	 	Title:	 	 
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Date:

	 	 	 	 	 	Date:	 	 
	 

	 	 
	 	 	 	 	 	 

 

****Certain confidential information contained in this document, marked with four asterisks,
has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]